A Phase 2 Study of Barzolvolimab in Patients With Eosinophilic Esophagitis

Status:
Not yet recruiting

Trial end date:
2025-08-01

Target enrollment:

Participant gender:

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adult Eosinophilic Esophagitis patients.

Phase 2

Celldex Therapeutics